Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Leases: 2022

Historic Capital Leases for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to $1.6 million.

  • Lexeo Therapeutics' Capital Leases was N/A to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Lexeo Therapeutics' Capital Leases is $1.6 million.
  • In the past 5 years, Lexeo Therapeutics' Capital Leases registered a high of $1.6 million during FY2022, and its lowest value of $1.6 million during FY2022.
  • Its 1-year average for Capital Leases is $1.6 million, with a median of $1.6 million in 2022.